tiprankstipranks
Advertisement
Advertisement
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
PremiumTipRanks NewswireNasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
3M ago
Nasus Pharma’s NS002 Outperforms EpiPen in Phase 2 Anaphylaxis Study, Pivotal Trial Planned for Late 2026
Premium
Company Announcements
Nasus Pharma’s NS002 Outperforms EpiPen in Phase 2 Anaphylaxis Study, Pivotal Trial Planned for Late 2026
3M ago
Nasus Pharma announces topline data from Phase 2 clinical study of NS002
Premium
The Fly
Nasus Pharma announces topline data from Phase 2 clinical study of NS002
3M ago
Nasus Pharma Prices $15 Million Premium Private Placement to Fund NS002 Pivotal Push
PremiumCompany AnnouncementsNasus Pharma Prices $15 Million Premium Private Placement to Fund NS002 Pivotal Push
5M ago
Nasus Pharma Ltd trading resumes
Premium
The Fly
Nasus Pharma Ltd trading resumes
5M ago
Nasus Pharma Ltd trading halted, volatility trading pause
Premium
The Fly
Nasus Pharma Ltd trading halted, volatility trading pause
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100